Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:07:02.245Z.
Calculation as of: 2026-10-06T14:07:02.245Z.
Quote observation: 2026-10-06T14:05:16.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 88e906b5462319013e69f4ee379284aaffb96e00f9acc248208650345dd3e90c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$6.68B
Operating Cash Flow Yield
5.84%
TTM Avg
6.63%
3Y Avg
5.04%
5Y Avg
4.66%
Market Cap
$6.55B
Operating Cash Flow Yield
4.07%
TTM Avg
4.34%
3Y Avg
3.15%
5Y Avg
2.87%
Market Cap
$6.53B
Operating Cash Flow Yield
6.32%
TTM Avg
8.37%
3Y Avg
7.89%
5Y Avg
6.14%
Market Cap
$6.52B
Operating Cash Flow Yield
3.08%
TTM Avg
6.96%
3Y Avg
12.38%
5Y Avg
19.52%
Market Cap
$7.04B
Operating Cash Flow Yield
3.57%
TTM Avg
7.35%
3Y Avg
8.10%
5Y Avg
6.33%
Market Cap
$7.25B
Operating Cash Flow Yield
N/A
TTM Avg
1.43%
3Y Avg
2.15%
5Y Avg
3.31%
Market Cap
$6.12B
Operating Cash Flow Yield
2.15%
TTM Avg
1.51%
3Y Avg
3.26%
5Y Avg
5.50%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunovant, Inc. (IMVT) | $6.75B | N/A | N/A | N/A | N/A |
| GRAIL Inc. (GRAL)vs › | $6.74B | N/A | N/A | N/A | N/A |
| Chemed Corporation (CHE)vs › | $6.68B | 5.84% | 6.63% | 5.04% | 4.66% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.55B | 4.07% | 4.34% | 3.15% | 2.87% |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.53B | 6.32% | 8.37% | 7.89% | 6.14% |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.52B | 3.08% | 6.96% | 12.38% | 19.52% |
| Alkermes plc (ALKS)vs › | $7.04B | 3.57% | 7.35% | 8.10% | 6.33% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.25B | N/A | 1.43% | 2.15% | 3.31% |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $6.12B | 2.15% | 1.51% | 3.26% | 5.50% |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $6.00B | N/A | 100.19% | 100.19% | 100.19% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
